Results 221 to 230 of about 893,446 (263)

Current development of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies (Review). [PDF]

Mol Med Rep
Zhang T, Yang D, Tang L, Hu Y.
europepmc   +1 more source

In silico exploration of natural xanthone derivatives as potential inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication and cellular entry. [PDF]

J Comput Aided Mol Des
Obakachi VA, Nchiozem-Ngnitedem VA, Govender KK, Govender PP.   +3 more
europepmc   +1 more source

Positive impact of nutrition in the prevention of peripheral vascular disease and severe acute respiratory syndrome coronavirus 2: review. [PDF]

Front Nutr
Karim ZA, Reese RA, Smith AN, Blackadar ME, Arora V, Moore NM, Johnson EA.   +6 more
europepmc   +1 more source

Association between chronic health conditions and severe acute respiratory syndrome in pregnant women: an exploratory study. [PDF]

Rev Esc Enferm USP
Lira Neto JCG, Araújo MFM, Monteiro FPM, Freitas RWJF, Teixeira CRS, Santos FS, Costa ACPJ, Santos Neto M, Pascoal LM.   +8 more
europepmc   +1 more source

Absence of cardiac impairment in patients after severe acute respiratory syndrome coronavirus type 2 infection: A long-term follow-up study. [PDF]

J Cardiovasc Magn Reson
Salatzki J, Ochs A, Weberling LD, Heins J, Zahlten M, Whayne JG, Stehning C, Giannitsis E, Denkinger CM, Merle U, Buss SJ, Steen H, André F, Frey N.   +13 more
europepmc   +1 more source

Severe acute respiratory syndrome (SARS) mathematical models and disease parameters: a systematic review and meta-analysis

Morgenstern C, Rawson T, Routledge I, Kont M, Imai-Eaton N, Skarp J, Doohan P, McCain K, Johnson R, Unwin HJT, Naidoo T, Dee DP, Parchani K, Cracknell Daniels BN, Vicco A, Drake KO, Christen P, Sheppard RJ, Leuba SI, Hicks JT, McCabe R, Nash RK, Santoni CN, Pathogen Epidemiology Review Group, Cuomo-Dannenburg G, van Elsland S, Bhatia S, Cori A.   +27 more
europepmc   +1 more source

BCG-Induced DNA Methylation Changes Improve Coronavirus Disease 2019 Vaccine Immunity Without Decreasing the Risk for Severe Acute Respiratory Syndrome Coronavirus 2 Infection. [PDF]

Open Forum Infect Dis
Carrero Longlax S, Koster KJ, Kamat AM, Lozano M, Lerner SP, Hannigan R, Nishiguchi T, Abhimanyu, Sheikh D, Ladki M, Portillo A, Koirala A, Patel TD, Spieler Z, Benjamin AB, Lebedev M, Ofili TU, Hutchison RW, Udeani G, Opperman LA, Neal G, Mandalakas AM, Netea MG, Arditi M, Avalos P, Grimm SL, Coarfa C, Cirillo JD, DiNardo AR.   +28 more
europepmc   +1 more source

Outcome of Glomerular Disease Manifesting After Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2. [PDF]

Cureus
Roy S, Kaul A, Yachha M, Prasad P, Kushwaha RS, Patel M, Prasad N, Jain M, Behera MR.   +8 more
europepmc   +1 more source

Validation of an interferon-gamma enzyme-linked immunosorbent spot assay to evaluate cell-mediated immunity against severe acute respiratory syndrome coronavirus 2. [PDF]

Hum Vaccin Immunother
Kim Y, Jang EJ, Hwang JY, Lee KM, Xayaheuang S, Choi ST, Park H.   +6 more
europepmc   +1 more source

One-pot MCDA-CRISPR-Cas-based detection platform for point-of-care testing of severe acute respiratory syndrome coronavirus 2. [PDF]

Front Microbiol
Wang X, Yang R, Tang T, Zhou Y, Chen H, Jiang Y, Zhang S, Qin S, Wang M, Wang C.   +9 more
europepmc   +1 more source